2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Path: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo - Shigella | Phase 2 | Terminated | University of Maryland, Baltimore | 20 | 2010-01-01 | 2021-04-29 |
| Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a - Shigella | Phase 2 | Terminated | University of Maryland, Baltimore | 20 | 2010-01-01 | 2021-04-29 |
Vaccines (1)
United States (2)